BDTX: Black Diamond Therapeutics Inc

BDTX新闻

• 15:16 BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst
• 15:13 Black Diamond Stock Outlook After Q1 Beat and Cash Runway
• 15:10 BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know
• 15:31 What's Going On With Black Diamond Therapeutics Stock Tuesday? - Black Diamond Therapeutic (NASDAQ:BDTX)
• 14:53 BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data
• 15:48 BDTX Shares Gain 11% in a Week: Here's What You Should Know
• 11:05 Implied Volatility Surging for Black Diamond Therapeutics Stock Options
• 15:29 BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize
• 15:26 BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right
• 15:23 Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks
• 15:30 Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?
• 16:21 BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026
• 16:20 Black Diamond Stock: Weighing Catalysts vs. Concentration
• 16:12 BDTX: What Silevertinib Data Say About EGFR NSCLC Upside
• 12:53 Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)
• 13:10 DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier
• 14:40 Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?
• 17:00 What Makes Black Diamond (BDTX) a New Strong Buy Stock
• 11:23 New Strong Buy Stocks for January 9th
• 14:35 Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)
• 13:06 Stifel维持Black Diamond Therapeutics股票买入评级，目标价8美元
• 13:05 Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8
• 09:30 This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Black Diamond Therapeutic (NASDAQ:BDTX), EastGroup Properties (NYSE:EGP)
• 13:31 Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data - Black Diamond Therapeutic (NASDAQ:BDTX)